RFK Jr. and the FDA: A Post-Regulatory Landscape?
The Core of the Critique On the coronary heart of RFK Jr.’s critique lies a basic mistrust of the FDA and its interactions with the pharmaceutical trade. He argues that the company is riddled with conflicts of curiosity, usually prioritizing the monetary good points of drug corporations over the well being and well-being of the … Read more
